Effect of Tvns in Obesity

Effect of AURICULAR Vagus Nerve Stimulation on Glucose Tolerance, and Mood States in Obesity

NCT07334951•Cairo University

View on ClinicalTrials.gov

Summary

Avoid unhealthy foods, walk every day for at least 15 min , sleep well, he should take sessions at its time, family should Avoid disturbances, keep quiet as much as possible, make Analysis recoired before and after interaction.

Detailed Description

Pre and post Anthrompometric measurement,waist circumference, body composition, lab tests, mood assessment, tVNS application, data management will be carried out using SPSSv26.

Eligibility

Age

40 - 50 years

Sex

ALL

Healthy Volunteers

Exclusion Criteria

•\-

Locations (1)

Tanta general hospital

Tanta, Algarbia, Egypt

Key Dates

Start Date

January 11, 2026

Primary Completion Date

August 21, 2026

Completion Date

August 21, 2026

Last Updated

January 13, 2026

Enrollment

ESTIMATED participants

Conditions

Obesity and Diabetes Mellitus, Type 2

Interventions

Trans vagus nerve stimulation electrical device.

DEVICE

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

NCT06959901

Obesity and Diabetes Mellitus, Type 2Diabetes Prevention

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 13, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions